POSEIDON INTERNATIONAL MARITIME SERVICES INC Manning Agency S-502 BEL AIR APT 1020 ROXAS BLVD ERMITA

MANILA Tel No/s : 5362703/5362714 Email Address : poseidonintl@pldtdsl.net Website : www.poseidonph.com Official Representative : MR FILOMENO S ORTIZ JR Status : Good Standing License Validity : 3/10/2008 to 3/9/2012
NOTE: The list includes all recruitment agencies licensed by POEA to recruit Filipino workers for overseas jobs, both land-based and sea-based. Also included were agencies which have been closed down or permanently banned from participating in the recruitment industry and agencies with licenses which were cancelled or suspended.

FDA Takes Action to Fill Drug Shortages

Posted 6 days ago in Pharma Industry News. FDA takes action to fill drug shortages [The Philadelphia Inquirer] From Philadelphia Inquirer (PA) (February 22, 2012) Feb. 22--With her 6-year-old son, Nate, fighting a form of leukemia, Sarah Stuckey was relieved to sit near federal officials and drugmakers Tuesday as they described solutions to two of the hundreds of drug shortages affecting patients in America. For the immediate...

Targeting Drug Shortage, Fabry's Patients Sue FDA

Posted 6 days ago in Pharma Industry News. Targeting drug shortage, Fabry's patients sue FDA [Pittsburgh Post-Gazette] From Pittsburgh PostGazette (PA) (February 22, 2012) Feb. 21--Two attorneys including one from McCandless and 25 people with treatable medical conditions including several from Southwestern Pennsylvania sued the Food and Drug Administration in federal court today, accusing it of failing to address a...

FDA Takes Action to Fill Drug Shortages

Posted 6 days ago in Pharma Industry News. FDA takes action to fill drug shortages [The Philadelphia Inquirer] From Philadelphia Inquirer (PA) (February 22, 2012) Feb. 22--With her 6-year-old son, Nate, fighting a form of leukemia, Sarah Stuckey was relieved to sit near federal officials and drugmakers Tuesday as they described solutions to two of the hundreds of drug shortages affecting patients in America. For the immediate...

Targeting Drug Shortage, Fabry's Patients Sue FDA

Targeting drug shortage, Fabry's patients sue FDA [Pittsburgh Post-Gazette] From Pittsburgh PostGazette (PA) (February 22, 2012) Feb. 21--Two attorneys including one from McCandless and 25

people with treatable medical conditions including several from Southwestern Pennsylvania sued the Food and Drug Administration in federal court today, accusing it of failing to address a...

Autoinjector Version of MS Drug Approved

TUESDAY, Feb. 28 -- A pen-delivery version of the multiple sclerosis drug Avonex has been approved by the U.S. Food and Drug Administration, drug manufacturer Biogen Idec said Tuesday. The self-administering Avonex autoinjector pen is designed to lessen pain and anxiety associated with MS, the Associated Press reported. The drug was first approved in 1996. On Tuesday, the FDA also approved new dosing guidelines to help cut down on flu-like symptoms, a common adverse reaction to the drug, the...

US Industry Bickers Over How to Capture Fake Drugs

From Associated Press (February 17, 2012) WASHINGTON -- The news this week that a fake version of the cancer medicine Avastin has made its way into the United States highlights a longtime concern: There are few safeguards to make sure fake drugs can be spotted before they make it into American doctors' offices. For more than a decade, public safety advocates have demanded a tracking system...

Manufacturers, Market Have Role in Drug Shortages, Sebelius Says

Manufacturers, market have role in drug shortages, Sebelius says [The Philadelphia Inquirer] From Philadelphia Inquirer (PA) (February 17, 2012) Feb. 17--Health and Human Services Secretary Kathleen Sebelius said Thursday in Philadelphia that the federal government is doing all it can legally to alleviate drug shortages, but that manufacturers and market forces play the biggest...

Chelsea Therapeutics CEO to Review Northera NDA and Provide an Update on Upcoming Advisory Committee Meeting During Presentation at BIO CEO
CHARLOTTE, N.C., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. announced that during a presentation at the 14th Annual BIO CEO and Investor Conference president and CEO, Dr. Simon Pedder, plans to provide an update regarding the company's New Drug Application (NDA) for Northera (droxidopa), an overview of key issues identified in the FDA briefing document...